Last reviewed · How we verify
Efficacy Comparison Between Two Kind of Chinese Herbal Formulas on Traditional Chinese Medicine Syndromes Among Chronic Hepatitis Patients
Although the incidence of Hepatitis B has been decreased a lot recently years, there are still quite a few chronic hepatitis B patients in China. The anti-virus drugs of western medicine such as Entecavir and Tenofovir have been proved effective on decreasing the serum hepatitis B virus (HBV) level, on the other hand, Chinese materia medica showed effective on TCM syndromes of chronic hepatitis B (CHB) such as hypochondriac pain, jaundice and abdominal mass. Besides, the hepatic fibrosis could be delayed after the appropriate treatment of TCM. This study is a multicenter, randomized, open label, parallel group clinical trial to evaluate the efficacy of two different traditional Chinese medicine (TCM) herbal treatment on chronic hepatitis B.
Details
| Lead sponsor | Xi'an Traditional Medicine Hospital |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 250 |
| Start date | 2017-01 |
| Completion | 2017-12 |
Conditions
- Hepatitis B， Chronic
Interventions
- Standard - Yinchengao Decoction plus Ganlu Detoxification Pill
- Entecavir or Tenofovir
- Standard - Ge Xia Zhu Yu Decoction
- Advanced - Supplemented Taohong Huazhuo Decoction
- Standard - Chaihu Shugan San
- Advanced - Soothe the liver and regulate qi Decoction
- Standard - Xiaoyao powder
- Advanced - Supplemented Ganbi Decoction
- Standard - Yiguan Decoction
- Advanced - Supplemented Zimu Dan
Primary outcomes
- Traditional Chinese Medicine symptom scale — Change of TCM symptom scale between baseline and sixth months of treatment
Countries
China